Mackay Shields LLC’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Mackay Shields LLC’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-104,390	Closed	-$1.88M	–	1612
2020 Q2	$1.88M	Buy	104,390 +800	+0.8%	+$11.1K	0.02%	788
2020 Q1	$738K	Buy	103,590 +44,400	+75%	+$554K	0.01%	1040
2019 Q4	$1.41M	Sell	59,190 -900	-1%	-$24.8K	0.01%	988
2019 Q3	$1.61M	Sell	60,090 -1,500	-2%	-$42.1K	0.01%	987
2019 Q2	$1.67M	Buy	61,590 +39,452	+178%	+$1.24M	0.01%	973
2019 Q1	$768K	Buy	22,138 +100	+0.5%	+$2.88K	0.01%	1072
2018 Q4	$430K	Sell	22,038 -1,676	-7%	-$34.5K	﹤0.01%	1186
2018 Q3	$632K	Buy	23,714 +2,700	+13%	+$88.2K	﹤0.01%	968
2018 Q2	$794K	Buy	21,014 +800	+4%	+$30.6K	0.01%	1015
2018 Q1	$660K	Buy	+20,214	New	+$887K	﹤0.01%	1070

Mackay Shields LLC's PTLA Position: Q3 2020 in Review

Mackay Shields LLC sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 104,390 shares — an estimated $1.88M sold.

Mackay Shields LLC first reported a position in PTLA in Q1 2018 and held it in 10 quarters. The position peaked at $1.88M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Mackay Shields LLC reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Mackay Shields LLC sold 104,390 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1.88M.
Mackay Shields LLC first reported a position in Portola Pharmaceuticals, Inc. in Q1 2018 and held it in 10 quarters.
Mackay Shields LLC's Portola Pharmaceuticals, Inc. position peaked at $1.88M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Mackay Shields LLC's 13F filing for Q3 2020, filed 4 Nov 2020.